The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy

Quantitative chemical shift imaging (QCSI) is the most sensitive imaging biomarker to assess bone marrow involvement in Gaucher disease. Widespread QCSI use is limited by test availability. Anecdotal reports describe two patients demonstrating significant improvement in fat fraction (FF) assessed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimran, Ari, Szer, Jeff, Becker-Cohen, Michal, Jens, Sjoerd, Cozma, Claudia, Revel-Vilk, Shoshana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054405/
https://www.ncbi.nlm.nih.gov/pubmed/36983221
http://dx.doi.org/10.3390/jcm12062220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054405/
https://www.ncbi.nlm.nih.gov/pubmed/36983221
http://dx.doi.org/10.3390/jcm12062220

Ejemplares similares